Cancer Colorectal clinical trials at UCSF
1 research study open to eligible people
Colorectal cancer is a disease that affects the colon or rectum. UCSF is studying how teams and technology can improve colonoscopy attendance after abnormal test results. This helps in early cancer detection and prevention.
IMProving Adherence to Colonoscopy Through Teams and Technology
open to eligible people ages 18 years and up
Complete and timely colonoscopy after an abnormal stool-based colorectal cancer screening test results in early detection, cancer prevention, and reduction in mortality, but follow-up in safety-net health systems occurs in less than 50% at 6 months. The proposal will implement multi-level approach consisting of a stepped-wedge clinic-level intervention of team-based best practices co-developed with primary and specialty care, a patient-level technology intervention to provide enhanced instructions and navigation to complete diagnostic colonoscopy, and a mixed methods evaluation to explore multi-level factors contributing to intervention outcomes. Developing a solution to this high-risk and diverse population has the potential to translate to other health systems, support patient self-management, and address other patient conditions.
San Francisco, California
Our lead scientists for Cancer Colorectal research studies include Ma Somsouk, MD, MAS Urmimala Sarkar, MD, MPH.
Last updated: